Trial: 201807099

Novel CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy

Phase

I

Principal Investigator

Dehdashti, Farrokh

Disease Site

Pancreas

Learn more about this study at: clinicaltrials.gov